Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2024-05-09 | 2024-05-30 | 227489 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2019-09-26 | 2020-03-10 | 94877 |
TEVA-FAMOTIDINE | 40MG | TABLET | Resolved | 2019-09-26 | 2020-03-10 | 94880 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2021-09-02 | 2021-09-23 | 145112 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2021-11-11 | 2022-01-07 | 149105 |
TEVA-FAMOTIDINE | 40MG | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151456 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2022-09-30 | 2022-12-15 | 170784 |
TEVA-FEBUXOSTAT | 80MG | TABLET | Resolved | 2022-07-25 | 2023-01-12 | 165456 |
TEVA-FEBUXOSTAT | 80MG | TABLET | Resolved | 2023-10-05 | 2024-02-08 | 206434 |
TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2017-09-21 | 2017-11-07 | 22948 |
TEVA-FENTANYL | 75MCG | PATCH | Resolved | 2019-07-02 | 2019-08-06 | 88158 |
TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2020-01-30 | 2020-02-13 | 104893 |
TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2020-04-23 | 2020-05-21 | 113025 |
TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-02-24 | 2022-04-09 | 155560 |
TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2022-03-24 | 2022-04-09 | 157247 |
TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2022-06-30 | 2022-08-09 | 163936 |
TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-06-30 | 2022-09-23 | 163939 |
TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2022-08-18 | 2022-09-23 | 167218 |
TEVA-FENTANYL | 75MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173013 |
TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173016 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |